Browsing: market

Moderna (NASDAQ:MRNA), an mRNA medicine and preventive vaccines provider, closed at $174.38, up 176.97%. Shares surged after Moderna and Merckreported positive Phase 3 melanoma data. Investors are watching for FDA plans and further developments for the treatment. Trading volume reached 185.1M shares, coming in about 1,819% above its three-month average of 9.6M shares. Moderna IPO’d…

After the Minnesota Vikings beat the New York Giants in their first preseason game, we have some more tangible play on which to base early evaluations of players on the Vikings’ roster. So which players helped their cause on Saturday- and which ones hurt it? Here is a stock market report for the Vikings as…